IRWD : Analysis & Opinions

  1. Ironwood Pharmaceuticals, Inc. (IRWD): New Analyst Report from ...

    December 23, 2014
    Ironwood reported a loss of $0.30 per share in the third quarter of 2014, narrower than the year-ago loss of $0.51 and the ...
  2. Impax Launches Opana ER Generic - Analyst Blog

    January 7, 2013
    Global Pharmaceuticals, the generic division of Impax Laboratories, Inc. (IPXL), a specialty pharmaceutical company, recently ...
  3. Pipeline Progress at Synergy Pharma - Analyst Blog

    December 31, 2012
    Synergy Pharmaceuticals (SGYP) recently initiated a phase IIb study with plecanatide for the treatment of patients suffering ...
  4. IPO Market Slows Down With Market Correction

    February 10, 2010
    The initial public offering market has recently hit a few bumps, as investors become nervous about the overall stock market.
Trading Center